0.38Open0.21Pre Close7 Volume71 Open Interest69.00Strike Price214.00Turnover46.54%IV5.67%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.1330Delta0.0589Gamma291.32Leverage Ratio-0.0901Theta-0.0011Rho-38.75Eff Leverage0.0169Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet